Overweight
Showing NaN - NaN of 31
Obesity, Overweight Trial in Puerto Rico, United States (Tirzepatide, Semaglutide 2.4 mg)
Recruiting
- Obesity
- Overweight
- Tirzepatide
- Semaglutide 2.4 mg
-
Birmingham, Alabama
- +31 more
Apr 26, 2023
Type 2 Diabetes, Obesity, Overweight or Obesity Trial in Worldwide (Orforglipron, Insulin Glargine)
Recruiting
- Type 2 Diabetes
- +5 more
- Orforglipron
- Insulin Glargine
-
Muscle Shoals, Alabama
- +320 more
Apr 12, 2023
Overweight, Overweight and Obesity, Overweight or Obesity Trial in New York (Counseling, Text Messages, Phone calls)
Recruiting
- Overweight
- +4 more
- Counseling
- +3 more
-
New York, New YorkMexican Consulate's Ventanilla de Salud (VDS)
Mar 20, 2023
Overweight, Obesity Trial in Worldwide (Semaglutide, Placebo (semaglutide))
Active, not recruiting
- Overweight
- Obesity
- Semaglutide
- Placebo (semaglutide)
-
Birmingham, Alabama
- +804 more
Dec 19, 2022
Anovulatory Disorders in Lean and Overweight Women
Recruiting
- Menstrual Cycle Abnormal
- +3 more
-
New York, New YorkClinical and Translational Science Center
Sep 23, 2022
Overweight, Obesity Trial in Worldwide (Gelesis100, )
Completed
- Overweight
- Obesity
- Gelesis100
- placebo
-
Anaheim, California
- +35 more
Aug 8, 2022
Overweight, Obesity Trial in Worldwide (Tirzepatide, Placebo)
Active, not recruiting
- Overweight
- Obesity
- Tirzepatide
- Placebo
-
Pelham, Alabama
- +119 more
Apr 12, 2022
Obesity, Overweight Trial in New York (Peer Assisted Lifestyle, Enhanced Usual Care)
Completed
- Obesity
- Overweight
- Peer Assisted Lifestyle
- Enhanced Usual Care
-
New York, New YorkManhattan Campus of the VA NY Harbor Healthcare System, New York
Feb 9, 2022
Digital Healthy Habits Program for Individuals With Breast
Active, not recruiting
- Cancer
- +4 more
-
New York, New YorkNoom, Inc
Nov 17, 2021
Schizophrenia, Schizoaffective Disorder, Overweight Trial in United States (Lorcaserin, Metformin, Placebo)
Obesity, Overweight, Fatty Liver Trial in New York (Almond, Cereal Bar)
Completed
- Obesity
- +3 more
- Almond
- Cereal Bar
-
New York, New YorkNew York Nutrition Obesity Research Center
Jan 9, 2020
Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)
Completed
- Cardiovascular Disease
- +4 more
- Lorcaserin hydrochloride
- Placebo
-
Alexander City, Alabama
- +498 more
Jun 27, 2019
Overweight, Pregnancy Trial in New York (Intensive Lifestyle Intervention (ILI), Usual Care)
Completed
- Overweight
- Pregnancy
- Intensive Lifestyle Intervention (ILI)
- Usual Care
-
New York, New YorkColumbia University Medical Center
Jan 30, 2019
Obesity, Overweight Trial in United States (Active Elipse Device, Elipse Sham Device)
Unknown status
- Obesity
- Overweight
- Active Elipse Device
- Elipse Sham Device
-
Scottsdale, Arizona
- +11 more
Aug 7, 2018
A Post-approval LAP-BAND® Lower Body Mass Index (LBMI) Study
Terminated
- Obesity
- Overweight
-
Fountain Valley, California
- +10 more
Jun 25, 2018
Overweight, Obesity Trial in Bronx, New York (Group 1, Group 2)
Completed
- Overweight
- Obesity
- Group 1
- Group 2
-
Bronx, New York
- +5 more
Feb 17, 2017
Obesity, Overweight, Pediatric Obesity Trial in New York (Melt Test Blend 3.2, Corn Oil)
Completed
- Obesity
- +2 more
- Melt Test Blend 3.2
- Corn Oil
-
New York, New YorkNew York Nutrition Obesity Research Center
Jan 30, 2017
Diabetes, Hypertension, Pre-diabetes Trial in New York (Stress Reduction& Healthy living)
Unknown status
- Diabetes
- +6 more
- Stress Reduction& Healthy living
-
New York, New YorkMt Sinai Medical Center
Dec 31, 2015
Overweight Trial in New York (Leptin, Placebo)
Completed
- Overweight
- Leptin
- Placebo
-
New York, New YorkColumbia University Medical Center
Oct 16, 2015